Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study-Reference-Cited by-同舟云学术

Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study

Published:2017-05-05 Issue:2 Volume:4 Page:82-92
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Fröhlich Hanna¹,Henning Felix¹,Täger Tobias¹,Schellberg Dieter¹,Grundtvig Morten²,Goode Kevin³,Corletto Anna¹,Kazmi Syed³,Hole Torstein⁴⁵,Katus Hugo A¹,Atar Dan⁶,Cleland John G F⁷⁸,Agewall Stefan⁶,Frankenstein Lutz¹,Clark Andrew L³

Affiliation:

1. Department of Cardiology, Angiology and Pulmology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany

2. Department of Medicine, Innlandet Hospital Trust Division Lillehammer, Lillehammer, Norway

3. Hull York Medical School, Castle Hill Hospital, Hull, UK

4. Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

5. Medical Clinic, Helse Møre and Romsdal HF, Ålesund, Norway

6. Department of Cardiology, Oslo University Hospital, Ulleval and Institute of Clinical Sciences, University of Oslo, Oslo, Norway

7. National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, UK

8. Robertson Centre for Biostatistics and Clinical Trials, Glasgow, UK

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/4/2/82/24260509/pvx013.pdf

Reference27 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Eur Heart J,2016

2. ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America;J Am Coll Cardiol,2016

3. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials;Garg;JAMA,1995

4. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);The CONSENSUS Trial Study Group;N Engl J Med,1987

5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication Adherence With Polypill in Cardiovascular Disease and High-Risk Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Involving 7364 Participants;Current Problems in Cardiology;2024-01

2. Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives;Biomedicines;2023-12-15

3. Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy;Circulation: Genomic and Precision Medicine;2023-08

4. Cardiovascular medication seems to promote recovery of autonomic dysfunction after stroke;Journal of Neurology;2022-06-12

5. Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in Japan;INQUIRY: The Journal of Health Care Organization, Provision, and Financing;2022-01